Ichikura Kanako, Nakayama Nao, Matsuoka Shiho, Ariizumi Yosuke, Sumi Takuro, Sugimoto Taro, Fukase Yuko, Murayama Norio, Tagaya Hirokuni, Asakage Takahiro, Matsushima Eisuke
Department of Health Sciences, School of Allied Health Sciences, Kitasato University, Japan.
Liaison Psychiatry and Psycho-oncology Unit, Department of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan.
Int J Clin Health Psychol. 2020 Sep-Dec;20(3):213-221. doi: 10.1016/j.ijchp.2020.06.003. Epub 2020 Jul 2.
BACKGROUND/OBJECTIVE: Patients with head and neck cancer (HNC) have some problems such as dysfunction of breathing, eating, and/or speaking. The aim of this study was to examine efficacy of the stress management program for HNC patients (SMAP-HNC) compared with usual care (UC).
We conducted a pilot study of SMAP-HNC for depressive HNC patients between January 2016 and March 2018. The program contains psychoeducation, stress coping training, and operant reinforcement. The outcome measure was the Hospital Anxiety and Depression Scale (HADS), Functional Assessment of Cancer Therapy (FACT), and Brief Coping Inventory (COPE).
Twenty patients were randomly assigned to SMAP-HNC and UC group. Although a small sample sizes, there was no significant difference of depression score change between SMAP-HNC and UC group (Hedges'd -0.83; 95% CI -1.80 to 0.13).
It was the first study to conduct stress management program for HNC patients. Unfortunately, our trial designed as a randomized controlled trial is underpowered to make conclusion as to the efficacy of SMAP-HNC. However, there are some valuable suggestions to modify the stress management program in future.
背景/目的:头颈癌(HNC)患者存在呼吸、进食和/或言语功能障碍等问题。本研究旨在比较头颈癌患者压力管理项目(SMAP-HNC)与常规护理(UC)的疗效。
2016年1月至2018年3月,我们对抑郁的头颈癌患者开展了SMAP-HNC的一项试点研究。该项目包括心理教育、压力应对训练和操作性强化。结局指标为医院焦虑抑郁量表(HADS)、癌症治疗功能评估(FACT)和简易应对方式问卷(COPE)。
20例患者被随机分配至SMAP-HNC组和UC组。尽管样本量较小,但SMAP-HNC组和UC组之间抑郁评分变化无显著差异(Hedges'd值为-0.83;95%CI为-1.80至0.13)。
这是首次针对头颈癌患者开展压力管理项目的研究。遗憾的是,我们作为随机对照试验设计的试验,在得出关于SMAP-HNC疗效的结论方面动力不足。然而,未来有一些修改压力管理项目的宝贵建议。